ProRx Pharma has announced the release of four injectables as part of its health and wellness product line, coupled with the ...

Sun Pharmaceuticals is one of India’s largest pharmaceutical companies with over 8% share in the domestic market. It owns 35 ...

It's unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is ...

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 10.66%, which has investors questioning if this is ...

The pharmaceutical manufacturing sector in Japan is poised for significant growth, with the market expected to surge from a valuation of US$ 34.7 billion in 2024 to a projected US ...

US market exposure limits Indian pharma's safe-haven appeal amid global volatility and tariff fears, but drugmakers focused ...